Clinical Trials Directory

Trials / Completed

CompletedNCT05864612

Tools for Anxiety and Depression Screening in Epilepsy

Developing Interoperable Tools for Anxiety and Depression Screening in Epilepsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
880 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A randomized trial to compare patient-completion success of REDCap and Electronic Health Record (EHR)-based anxiety \& depression instrument delivery methods. Study hypothesis is that the screening completion proportion will vary across the 4 modalities tested.

Detailed description

In this randomized study of four modalities, we will compare Twilio text message delivery via REDCap versus (vs.) REDCap email survey links vs. EHR portal questionnaires with reminder message vs. current standard delivery EHR portal questionnaires without reminder. Screening instruments will be delivered by randomized method 7 days prior to scheduled clinic visit and outcomes occur by the time of the scheduled clinic visit. The study setting is the Wake Forest Comprehensive Epilepsy Center, with 2 clinic sites where adult patients are served (Atrium Health Wake Forest Baptist main campus, Atrium Health High Point Medical Center). EHR portal questionnaires without reminder is the current standard care screener delivery method. An exploratory supplement randomizing individuals to text message versus email survey link was later added.

Conditions

Interventions

TypeNameDescription
BEHAVIORALScreening QuestionnairesStandard care screening questionnaires on anxiety and depression

Timeline

Start date
2023-09-20
Primary completion
2024-09-03
Completion
2024-09-03
First posted
2023-05-18
Last updated
2025-10-30
Results posted
2025-10-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05864612. Inclusion in this directory is not an endorsement.